Completed PHASE4 INTERVENTIONAL NCT00329615

Insulin Treatment in Cancer Cachexia

Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.

Sponsor: Göteborg University

Conditions Cancer Cachexia

Interventions Insulatard, flexpen

Updated 6 times since 2017 Last updated: Aug 20, 2009 Started: Jan 31, 2000 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00329615, this PHASE4 trial focuses on Cancer Cachexia and remains completed. Sponsored by Göteborg University, it has been updated 6 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Göteborg University
Medical Research Council
Swedish Cancer Foundation

Data source: Göteborg University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gothenburg, Sweden